Concepedia

Katia Balmas Bourloud

KB

Statistics

Publications

16

Citations

876

H-Index

16

Active since

2000

Affiliations

University Hospital of Lausanne(Current)

University of Lausanne

Institut Gustave Roussy

Institut Curie

Inserm

Katia Balmas Bourloud is an author at University Hospital of Lausanne specializing in oncology, molecular oncology, and neuroblastoma biology.

Publications per year

2000–2022

16

Publications

16

Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.

Sally Hopkins-Donaldson, Jean-Luc Bodmer, Katia Balmas Bourloud et al. · PubMed · 2000 · 247 citations

, , +17

Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP

Annick Mühlethaler‐Mottet, Katia Balmas Bourloud, Katya Auderset et al. · Oncogene · 2004 · 71 citations

, , +17

The Chemokine Receptor CXCR4 Strongly Promotes Neuroblastoma Primary Tumour and Metastatic Growth, but not Invasion

Roland Meier, Annick Mühlethaler‐Mottet, Marjorie Flahaut et al. · PLoS ONE · 2007 · 61 citations · Full text

, , +17

Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells

Annick Mühlethaler‐Mottet, Roland Meier, Marjorie Flahaut et al. · Molecular Cancer · 2008 · 59 citations · Full text

, , +13

Loss of caspase-8 expression in neuroblastoma is related to malignancy and resistance to TRAIL-induced apoptosis

Sally Hopkins-Donaldson, Jean-Luc Bodmer, Katia Balmas Bourloud et al. · Medical and Pediatric Oncology · 2000 · 53 citations

, , +17

1–5 of 16